Biomarin Pharmaceutical - Registered Shares Overview
Biomarin Pharmaceutical - Registered Shares Target Price
Analysts' 12-month price predictions for BMRN.
Get informed when a big investor buys or sells
+ FollowShare Price
$56.47
Average Target Price
$90.20
59.7% upside
59.7% upside15 analysts in the last 4 months
High: $120 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-22 | Canaccord Genuity | $111 | 96.6% upside |  |
| 2026-05-18 | Leerink Partners | $62 | 9.8% upside | |
| 2026-05-18 | H.C. Wainwright | $50 |  11.5% downside | |
| 2026-05-11 | Goldman Sachs | $69 | 22.2% upside | |
| 2026-05-05 | Evercore ISI | $120 | 112.5% upside | |
| 2026-05-05 | Tudor PickeringWilliam Pickering | $82 | 45.2% upside | |
| 2026-04-27 | Morgan StanleySean Laaman | $120 | 112.5% upside | |
| 2026-03-12 | JefferiesAkash Tewari | $103 | 82.4% upside | |
| 2026-03-03 | BarclaysEliana Merle | $105 | 85.9% upside | |
| 2026-03-02 | Loop Capital MarketsIlya Zubkov | $105 | 85.9% upside | |
| 2026-02-26 | Canaccord GenuityWhitney Ijem | $104 | 84.2% upside | |
| 2026-02-24 | Oppenheimer | $95 | 68.2% upside | |
| 2026-02-24 | Stifel NicolausPaul Matteis | $68 | 20.4% upside | |
| 2026-02-18 | Wells Fargo | $75 | 32.8% upside | |
| 2026-02-06 | Piper Sandler | $84 | 48.8% upside | |
| 2026-01-20 | Canaccord Genuity | $98 | 73.5% upside | |
| 2025-12-23 | Truist FinancialJoon Lee | $100 | 77.1% upside | |
| 2025-12-22 | H.C. Wainwright | $60 | 6.3% upside | |
| 2025-12-03 | Leerink Partners | $60 | 6.3% upside | |
| 2025-11-03 | Tudor PickeringWilliam Pickering | $88 | 55.8% upside | |
| 2025-11-03 | Bernstein | $88 | 55.8% upside | |
| 2025-10-28 | RBC CapitalLuca Issi | $66 | 16.9% upside | |
| 2025-10-28 | Stifel Nicolaus | $73 | 29.3% upside | |
| 2025-10-28 | Truist FinancialJoon Lee | $80 | 41.7% upside | |
| 2025-10-28 | Morgan StanleySean Laaman | $98 | 73.5% upside | |
| 2025-10-28 | H.C. Wainwright | $55 | 2.6% downside | |
| 2025-10-28 | Wells FargoMohit Bansal | $70 | 24% upside | |
| 2025-10-28 | Barclays | $80 | 41.7% upside | |
| 2025-08-05 | UBS | $114 | 101.9% upside | |
| 2025-07-15 | Wolfe ResearchAkash Tewari | $95 | 68.2% upside | |
| 2024-10-30 | Cantor FitzgeraldOlivia Brayer | $90 | 59.4% upside | |
| 2024-10-30 | Robert W. BairdJack Allen | $65 | 15.1% upside | |
| 2024-10-30 | CitigroupDavid Lebowitz | $81 | 43.4% upside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $79 | 39.9% upside | |
| 2024-10-04 | BarclaysGena Wang | $86 | 52.3% upside | |
| 2024-09-18 | CitigroupDavid Lebowitz | $93 | 64.7% upside | |
| 2024-09-17 | ScotiabankGeorge Farmer | $78 | 38.1% upside | |
| 2024-09-17 | Truist FinancialJoon Lee | $90 | 59.4% upside | |
| 2024-09-17 | BernsteinWilliam Pickering | $90 | 59.4% upside | |
| 2024-09-17 | BMO CapitalKostas Biliouris | $115 | 103.6% upside | |
| 2024-09-16 | BarclaysGena Wang | $110 | 94.8% upside | |
| 2024-09-05 | Raymond JamesChristopher Raymond | $122 | 116% upside | |
| 2024-09-05 | ScotiabankGeorge Farmer | $95 | 68.2% upside | |
| 2024-08-27 | Raymond JamesChristopher Raymond | $107 | 89.5% upside | |
| 2024-08-21 | Stifel NicolausPaul Matteis | $115 | 103.6% upside | |
| 2024-08-20 | Tudor PickeringWilliam Pickering | $110 | 94.8% upside | |
| 2024-08-06 | Stifel NicolausPaul Matteis | $112 | 98.3% upside | |
| 2024-08-06 | Evercore ISICory Kasimov | $115 | 103.6% upside | |
| 2024-08-06 | Canaccord GenuityWhitney Ijem | $93 | 64.7% upside | |
| 2024-06-27 | Wells FargoMohit Bansal | $115 | 103.6% upside | |